MORGAN BOWEN: Open Payments
NPI 1003410697 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 40 payments from 14 companies in 2025. Trend: 2023 $475 · 2024 $531 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $130 |
| Neurocrine BioSciences, Inc. | 6 | $123 |
| Alkermes, Inc. | 4 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| Lundbeck LLC | 2 | $48 |
| ABBVIE INC. | 3 | $46 |
| Biogen, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: REXULTI, Azstarys, INGREZZA, ARISTADA, AUSTEDO XR, SPRAVATO, VRAYLAR, ZURZUVAE.
Industry payments across MI — which companies pay providers there.
